Therapeutic Targeting of the Bcl-6: p53 Axis with Histone Deacetylase Inhibitors in Diffuse Large B-Cell Lymphoma

被引:0
|
作者
Amengual, Jennifer E. [1 ]
Kalac, Matko [1 ]
Scotto, Luigi [1 ]
Sleckman, Patrick A. [2 ]
Marchi, Enrica [1 ]
Deng, Changchun [1 ]
Bongero, Danielle C. [1 ]
Jain, Salvia [1 ]
Buitrago, Jairo Baquero [1 ]
O'Connor, Owen A. [1 ]
机构
[1] NYU Langone Med Ctr, NYU Canc Inst, New York, NY USA
[2] Lake Erie Coll Osteopath Med, Erie, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1593 / 1594
页数:2
相关论文
共 50 条
  • [21] Expression of CD10, Bcl-2, Bcl-6, Bcl-X and p53 in diffuse large B-cell lymphoma (DLBCL) using a high-throughput tissue microarray (TMA).
    Skacel, M
    Pohlman, B
    Tubbs, RR
    Hsi, ED
    MODERN PATHOLOGY, 2001, 14 (01) : 179A - 179A
  • [22] Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine
    Kwon, MS
    Go, JH
    Choi, JS
    Lee, SS
    Ko, YH
    Rhee, JC
    Ree, HJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) : 790 - 798
  • [23] Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
    Lossos, IS
    Jones, CD
    Warnke, R
    Natkunam, Y
    Kaizer, H
    Zehnder, JL
    Tibshirani, R
    Levy, R
    BLOOD, 2001, 98 (04) : 945 - 951
  • [24] BCL-6 Gene Abnormalities are Common in Primary Central Nervous System Diffuse Large B-Cell Lymphoma
    Martin, Sarah
    Czader, Magdalena
    Al-Abbadi, Mousa
    Stohler, Ryan
    Vance, Gail
    Hattab, Eyas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (05): : 548 - 549
  • [25] High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin
    Liang, R
    Chan, WP
    Kwong, KY
    Srivastava, G
    Faith, CSH
    BLOOD, 1996, 88 (10) : 3470 - 3470
  • [26] BCL-6 EXPRESSION IS A FAVOURABLE PROGNOSTIC FACTOR OF PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN
    Chung, K.
    Chang, S.
    Chuang, S. -S.
    ANNALS OF ONCOLOGY, 2011, 22 : 212 - 212
  • [27] High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin
    Liang, R
    Chan, WP
    Kwong, YL
    Xu, WS
    Srivastava, G
    Ho, FCS
    CANCER GENETICS AND CYTOGENETICS, 1997, 97 (02) : 114 - 118
  • [28] Targeting of the Bcl-6 oncoprotein with a specific peptide inhibitor reveals a critical role for Bcl-6 in lymphomagenesis and a potential novel transcription therapy approach for diffuse large B-cell lymphoma.
    Melnick, AM
    Delloso, T
    Ranuncolo, SM
    Takahashi, S
    Licht, JD
    Prive, GG
    Polo, J
    BLOOD, 2003, 102 (11) : 136A - 136A
  • [29] Prognostic significance of BCL-6 expression in diffuse large B-cell lymphomas (DLBCL)
    Karikehalli, S
    Nazeer, T
    LABORATORY INVESTIGATION, 2002, 82 (01) : 246A - 246A
  • [30] Detection of germinal center B-cell lymphoma in archival specimens: Critical evaluation of bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil
    Ree, HJ
    Ohsima, K
    Aozasa, K
    Takeuchi, K
    Kim, CW
    Yang, WI
    Huh, JY
    Lee, SS
    Ko, YH
    Kwon, MS
    Cho, EY
    Choi, YL
    Rhee, JC
    Kikuchi, M
    Mori, S
    HUMAN PATHOLOGY, 2003, 34 (06) : 610 - 616